Dr. Ingmar Gorman, Fluence

In this episode of the Psychedelic Spotlight podcast, we speak with Dr. Ingmar Gorman who is the Co-Founder and Lead Trainer at Fluence, and a Principal Investigator for the Multidisciplinary Association for Psychedelic Studies ("MAPS").In our conversation with Dr. Gorman, we learn about the educational and training resources Fluence is focused on developing to address the growing interest in psychedelic integration and psychedelic-assisted psychotherapy. Dr. Gorman is also kind enough to share his expertise and perspective as it relates to the encouraging results recently released surrounding the Phase 3 Trials testing MDMA-assisted psychotherapy for PTSD conducted by MAPS, and what it potentially means for the future of MDMA-assisted psychotherapy.*To learn more about the company featured in this episode and the work they’re doing, visit their website: FluenceTraining.com*Get the latest industry news around all things psychedelics by visiting our website and be sure to subscribe to our newsletter to never miss a thing. Visit our Website: PsychedelicSpotlight.comSubscribe to our YouTube ChannelFollow us on InstagramLike us on FacebookFollow us on Twitter*This episode was recorded on May 19, 2021.